RHOA and lipomatosis: For instance, when miR-125a-3p expression was up-regulated which then targeted RhoA leading to a down-regulation of RhoA/ROCK activity and followed by increased adipogenesis in subcutaneous WAT in patients with multiple symmetric lipomatosis (79).